OP
KITE

Omni Partners’s Kite Pharma, Inc. KITE Stock Holding History

Omni Partners’s Portfolio KITE Stock Details KITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-661,711
Closed -$119M – 37
2017
Q3 		$119M Buy
+661,711
New +$92.2M 15.19% 1

Omni Partners's KITE Position: Q4 2017 in Review

Omni Partners sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 661,711 shares — an estimated $119M sold.

Omni Partners first reported a position in KITE in Q3 2017 and held it in 1 quarter. The position peaked at $119M in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

  • Omni Partners reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
  • Omni Partners sold 661,711 Kite Pharma, Inc. shares in Q4 2017, an estimated $119M.
  • Omni Partners first reported a position in Kite Pharma, Inc. in Q3 2017 and held it in 1 quarter.
  • Omni Partners's Kite Pharma, Inc. position peaked at $119M in Q3 2017.
  • 0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on Omni Partners's 13F filing for Q4 2017, filed 22 Jan 2018.